| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.022 | 0.9 |